Literature DB >> 25648688

Etiological treatment of Chagas disease patients with benznidazole lead to a sustained pro-inflammatory profile counterbalanced by modulatory events.

A C Campi-Azevedo1, J A S Gomes2, A Teixeira-Carvalho1, D Silveira-Lemos1, D M Vitelli-Avelar1, R Sathler-Avelar1, V Peruhype-Magalhães1, S R Béla1, K F Silvestre3, M A Batista3, N C C Schachnik1, R Correa-Oliveira4, S M Eloi-Santos1, O A Martins-Filho1.   

Abstract

In the present study, we characterized the phagocytic capacity, cytokine profile along with the FCγ-R and TLR expression in leukocytes from Chagas disease patients (indeterminate-IND and cardiac-CARD) before and one-year after Bz-treatment (INDT and CARDT). A down-regulation of IL-17, IFN-γ and IL-10 synthesis by neutrophils was observed in CARDT. The Bz-treatment did not impact on the expression of phagocytosis-related surface molecules or monocyte-derived cytokine profile in INDT. Although CARDT showed unaltered monocyte-phagocytic capacity, up-regulated expression of Fcγ-RI/III and TLR-4 may be related to their ability to produce IL-10 and TGF-β. Down-regulation of lymphocyte-derived cytokine was observed in INDT whereas up-regulated cytokine profile was observed for lymphocytes in CARDT. Analysis of cytokine network revealed that IND displayed a multifaceted cytokine response characterized by strong connecting axes involving pro-inflammatory/regulatory phagocytes and lymphocytes. On the other hand, CARD presented a modest cytokine network. The Bz-treatment leads to distinct cytokine network: decreasing the links in INDT, with a pivotal role of IL-10(+) monocytes and expanding the connections in CARDT. Our findings highlighted that the Bz-treatment contributes to an overall immunomodulation in INDT and induces a broad change of immunological response in CARDT, eliciting an intricate phenotypic/functional network compatible with beneficial and protective immunological events.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Benznidazole treatment; Chagas disease; Cytokine profile; FCγ-R; Phagocytic capacity; TLR expression

Mesh:

Substances:

Year:  2015        PMID: 25648688     DOI: 10.1016/j.imbio.2014.12.006

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  8 in total

1.  Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease.

Authors:  Mónica Cristina García; Nicolás Eric Ponce; Liliana Maria Sanmarco; Rubén Hilario Manzo; Alvaro Federico Jimenez-Kairuz; Maria Pilar Aoki
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

2.  Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.

Authors:  Ágata Carolina Cevey; Gerardo Ariel Mirkin; Federico Nicolás Penas; Nora Beatriz Goren
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2015-12-12       Impact factor: 4.077

3.  Differential Expression of Matrix Metalloproteinases 2, 9 and Cytokines by Neutrophils and Monocytes in the Clinical Forms of Chagas Disease.

Authors:  Nayara I Medeiros; Rafaelle C G Fares; Eliza P Franco; Giovane R Sousa; Rafael T Mattos; Ana T Chaves; Maria do Carmo P Nunes; Walderez O Dutra; Rodrigo Correa-Oliveira; Manoel O C Rocha; Juliana A S Gomes
Journal:  PLoS Negl Trop Dis       Date:  2017-01-24

4.  IL-10/STAT3/SOCS3 Axis Is Involved in the Anti-inflammatory Effect of Benznidazole.

Authors:  Ágata C Cevey; Federico N Penas; Catalina D Alba Soto; Gerardo A Mirkin; Nora B Goren
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

5.  A proportion of CD4+ T cells from patients with chronic Chagas disease undergo a dysfunctional process, which is partially reversed by benznidazole treatment.

Authors:  Elena Pérez-Antón; Adriana Egui; M Carmen Thomas; Bartolomé Carrilero; Marina Simón; Miguel Ángel López-Ruz; Manuel Segovia; Manuel Carlos López
Journal:  PLoS Negl Trop Dis       Date:  2021-02-04

6.  Benznidazole Anti-Inflammatory Effects in Murine Cardiomyocytes and Macrophages Are Mediated by Class I PI3Kδ.

Authors:  Ágata C Cevey; Paula D Mascolo; Federico N Penas; Azul V Pieralisi; Aldana S Sequeyra; Gerardo A Mirkin; Nora B Goren
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

7.  Fenofibrate Increases the Population of Non-Classical Monocytes in Asymptomatic Chagas Disease Patients and Modulates Inflammatory Cytokines in PBMC.

Authors:  Azul V Pieralisi; Ágata C Cevey; Federico N Penas; Nilda Prado; Ana Mori; Mónica Gili; Gerardo A Mirkin; Juan Gagliardi; Nora B Goren
Journal:  Front Cell Infect Microbiol       Date:  2022-03-11       Impact factor: 5.293

8.  Distinct monocyte subset phenotypes in patients with different clinical forms of chronic Chagas disease and seronegative dilated cardiomyopathy.

Authors:  Damián E Pérez-Mazliah; Melisa D Castro Eiro; María Gabriela Álvarez; Bruno Lococo; Graciela Bertocchi; Gonzalo César; María A Natale; María C Albareda; Rodolfo Viotti; Susana A Laucella
Journal:  PLoS Negl Trop Dis       Date:  2018-10-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.